Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about Vulnerability: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No AI portrait yet
Knowledge base pages for this entity
| Target | Relation | Type | Str |
|---|---|---|---|
| No outgoing edges | |||
| Source | Relation | Type | Str |
|---|---|---|---|
| Frailty Index | biomarker_for | biomarker | 0.90 |
| 27555812 | is instrumental in mediating | paper | 0.60 |
Hypotheses where this entity is a therapeutic target
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| Plasma ATN biomarkers across AD continuum in Chilean cohort | clinical | Alzheimer's disease | 0.950 | 0.00 | Chilean older adults (n=318) w | proposed | N/A |
| Tau depletion effects on neuronal development in primary cultures | exploratory | 0.900 | 0.00 | primary rodent neuronal cultur | proposed | N/A | |
| Differential GWAS of schizophrenia vs PTSD | exploratory | schizophrenia, post-traumatic | 0.900 | 0.00 | human patients - European ance | proposed | N/A |
| Tau depletion effects on neuronal development in primary cultures | exploratory | 0.900 | 0.00 | primary rodent neuronal cultur | proposed | N/A | |
| Creation and validation of 3xAD-ChAT-Cre mouse model | validation | Alzheimer's disease | 0.900 | 0.00 | 3xAD-ChAT-Cre transgenic mice | proposed | N/A |
| CXCL10 biomarker analysis for CPSP prediction | clinical | chronic postsurgical pain | 0.900 | 0.00 | human patients undergoing thor | proposed | N/A |
| GTEx brain tissue expression analysis of MAPT/CRHR1 locus | exploratory | schizophrenia, post-traumatic | 0.850 | 0.00 | human brain tissue samples fro | proposed | N/A |
| Microtubule domain analysis in adult axons | exploratory | 0.800 | 0.00 | adult rodent axons | proposed | N/A | |
| Tau depletion effects on microtubule domains in adult axons | exploratory | 0.800 | 0.00 | adult rodent neurons | proposed | N/A | |
| bEV isolation and LPS quantification from human samples | clinical | Alzheimer's disease | 0.800 | 0.00 | human patients | proposed | N/A |
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Unveiling the choroidal immune landscape revealed interferon-gamma and TNF-alpha [PMID:41077603] | Ye L, Zhao T, Tian H, Li R, Li Z et al. | Sci China Life Sci | 2026 | 0 |
| The mechanism of Qing-Fei-Yin decoction against influenza: Synergistical inhibit [PMID:41317805] | Nie W, Wang M, Cheng M, Ren Z, Liu G et | J Ethnopharmacol | 2026 | 0 |
| Integrative Multiomics Insights into the Genetic and Epigenetic Architecture of [PMID:41422555] | Mishra AK, Jain S | ACS Chem Neurosci | 2026 | 0 |
| The association of Alzheimer's disease-related SNPs with mild cognitive impairme [PMID:41606232] | Xie Z, Tu W, Ye XF, Hua L, Zhang X et al | Sci Rep | 2026 | 0 |
| Genetic risk factors of late-onset Alzheimer's disease: Insights into pathophysi [PMID:41622452] | Akkaoui J, Devadoss D, Rodriguez MD, Ari | Neural Regen Res | 2026 | 0 |
| Indole-3-propionic acid inhibits astrocyte inflammation and promotes motor funct [PMID:41663028] | Yu D, Kang J, Jiang W, Zhang C, Zhao X e | Neuropharmacology | 2026 | 0 |
| Cobrotoxin mitigates neuroinflammation and cognitive impairment by suppressing C [PMID:41671614] | Li Z, Tan B, Dong K, Yu X, Zhang SW et a | Biochem Pharmacol | 2026 | 0 |
| Peripheral macrophages and T-cells accumulate in the degenerating optic tract af [PMID:41740873] | Main BS, Villapol S, Buenaventura RG, Ha | Brain Behav Immun | 2026 | 0 |
| Genetic Burden and <i>APOE</i> Methylation in a Korean Multi-Generational Alzhei [PMID:41745359] | Eom Je-Hyun; Cho Mu-Yeol; Kim Ji-Won; Ki | Journal of personalized medici | 2026 | 0 |
| Melanoma cell inoculation improves cognitive impairment in the 5xFAD mouse model [PMID:41760781] | Bruna-Jara B, More J, Lobos P, Ponce DP, | Scientific reports | 2026 | 0 |
| Microenvironment-educated MSC-EVs loaded injectable smart hydrogel for targeting [PMID:41799958] | Wu W, Cheng Z, Shi P, Gao H, Chen X et a | Bioact Mater | 2026 | 0 |
| Genetic Variation in the Chemokine Network and Atherosclerosis Risk. [PMID:41824188] | Zangas P, Georgakis MK | Curr Atheroscler Rep | 2026 | 0 |
| Genetic Architecture of Cognitive Resilience in Alzheimer's Disease: Mechanisms, [PMID:41893052] | Burdman Gabriel; Akkaoui Juliet; Colon N | Neurology international | 2026 | 0 |
| Posttraumatic stress disorder is associated with Alzheimer's disease-relevant mo [PMID:41960318] | Seijo MA, Yohannes PA, Rogers AL, Gonzal | Res Sq | 2026 | 0 |
| Genetic risk factors of late-onset Alzheimer's disease: Insights into pathophysi [PMID:41622452] | Akkaoui J, Devadoss D, Rodriguez MD, Ari | Neural regeneration research | 2026 | 0 |
| Genetic Architecture of Cognitive Resilience in Alzheimer's Disease: Mechanisms, [PMID:41893052] | ["Burdman G", "Akkaoui J", "Colon N", "P | Neurology international | 2026 | 0 |
| HTLV1-associated myelopathy as a translational model of progressive neurodegener [PMID:41926707] | da Silva MTT, Araujo AQC | Brain : a journal of neurology | 2026 | 0 |
| Sevoflurane aggravates hypoxic-ischemic encephalopathy in preterm neonates via V [PMID:40602692] | Qin M, Shi D, Song X, Zhang R, Feng Z, L | Brain research bulletin | 2025 | 0 |
| Audiogenic kindling activates glutamatergic system in the hippocampus of rats wi [PMID:38325559] | Aleksandrova EP, Ivlev AP, Kulikov AA, N | Brain research | 2024 | 0 |
| Icariin, astragaloside a and puerarin mixture attenuates cognitive impairment in [PMID:38412923] | ["Zhang Tian-Ci", "Lin Yi-Can", "Sun Nin | Neurochemistry international | 2024 | 0 |
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning Vulnerability in their description or question text
Score: 0.690 · neurodegeneration · 2026-04-22
## Mechanistic Overview Astrocyte Reactivity Heterogeneity with APOE4-Dependent Vulnerability starts from the claim that
Score: 0.675 · Alzheimer's Disease · 2026-04-02
## Mechanistic Overview Excitatory Neuron Vulnerability via SLC17A7 Downregulation starts from the claim that modulating
Score: 0.670 · neurodegeneration · 2026-04-21
## Mechanistic Overview OPTN/TBK1 mutations create selective vulnerability by blocking PINK1-Parkin-independent mitophag
Score: 0.667 · neurodegeneration · 2026-04-04
## Mechanistic Overview White Matter Vulnerability Prevention via Oligodendrocyte Protection starts from the claim that
Score: 0.656 · neurodegeneration · 2026-04-14
## Mechanistic Overview Parvalbumin Interneuron Vulnerability Links Lactate Transport to Gamma Oscillation Dysfunction s
Score: 0.651 · neurodegeneration · 2026-04-02
## Mechanistic Overview Oligodendrocyte White Matter Vulnerability starts from the claim that modulating MOG within the
Score: 0.638 · neurodegeneration · 2026-04-04
## Mechanistic Overview Selective Neuronal Vulnerability Network Targeting starts from the claim that modulating Cell-ty
Score: 0.636 · neurodegeneration · 2026-04-28
Layer 2/3 excitatory neurons show transcriptional signature of endoplasmic reticulum stress and mitochondrial dysfunctio
Score: 0.632 · Alzheimer's disease · 2026-04-04
## Mechanistic Overview Layer V excitatory neurons show selectively enhanced vulnerability through dysregulated calcium
Score: 0.630 · neurodegeneration · 2026-04-25
APOE4 may bias microglia toward complement-mediated pruning that disproportionately strips vulnerable long-range choline
Score: 0.626 · neurodegeneration · 2026-04-28
CCL2-CCR2 myeloid signaling as a selective driver of fast-fatigable motor-neuron denervation should produce a measurable
Score: 0.616 · neurodegeneration · 2026-04-13
## Mechanistic Overview Spatially-Targeted Regional Vulnerability Prevention starts from the claim that modulating Regio
Score: 0.612 · neurodegeneration · 2026-04-28
The question is likely underpowered or misleading unless analyses preserve the key strata: CCL2-CCR2, NMJ, ALS, CCR2. Av
Score: 0.608 · neurodegeneration · 2026-04-28
The debate supports treating this as a validation program before ranking it as a therapy. Perturbation should move a pro